Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551475/
https://www.ncbi.nlm.nih.gov/pubmed/37811251
http://dx.doi.org/10.1155/2023/9804628
_version_ 1785115775048089600
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10551475
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105514752023-10-06 Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-09-27 /pmc/articles/PMC10551475/ /pubmed/37811251 http://dx.doi.org/10.1155/2023/9804628 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
title Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
title_full Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
title_fullStr Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
title_full_unstemmed Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
title_short Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
title_sort retracted: efficacy, safety, and prognosis of sequential therapy with tamoxifen and letrozole versus letrozole monotherapy for breast carcinoma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551475/
https://www.ncbi.nlm.nih.gov/pubmed/37811251
http://dx.doi.org/10.1155/2023/9804628
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedefficacysafetyandprognosisofsequentialtherapywithtamoxifenandletrozoleversusletrozolemonotherapyforbreastcarcinoma

Ejemplares similares